Signaling Pathways - HDM2 ubiquitin ligase - Insulin and Insulin-like Receptors - p70 rsk - Bfl-1
清除全部
-
B5815 LY2584702Target: p70 rskSummary: P70 S6激酶抑制剂 -
B2228 PF-47086711 CitationTarget: p70 rskSummary: P70 S6K1亚型抑制剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A5653 AT7867Target: Akt|PKA|p70 rskSummary: Akt1/2/3和p70S6K/PKA的抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂 -
A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂，有效的胰岛素敏化剂 -
A4199 Sabutoclax2 CitationTarget: Bcl-2|Mcl-1|Bfl-1Summary: Pan-Bcl-2抑制剂 -
A4204 JNJ-26854165 (Serdemetan)1 CitationTarget: p53|HDM2 ubiquitin ligaseSummary: P53激活剂，阻断Mdm2-p53相互作用。